Variant report
| Variant | rs12260357 |
|---|---|
| Chromosome Location | chr10:50451265-50451266 |
| allele | G/T |
| Outlinks | Ensembl UCSC |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr10:50447600-50452400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
| 2 | chr10:50447600-50453000 | Enhancers | Primary monocytes fromperipheralblood | blood |
| 3 | chr10:50449000-50451400 | Enhancers | Left Ventricle | heart |
| 4 | chr10:50449000-50451400 | Enhancers | Right Atrium | heart |
| 5 | chr10:50449000-50451600 | Enhancers | Fetal Heart | heart |
| 6 | chr10:50449000-50451600 | Enhancers | Right Ventricle | heart |
| 7 | chr10:50449800-50451600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
| 8 | chr10:50449800-50451600 | Enhancers | K562 | blood |
| 9 | chr10:50449800-50452200 | Enhancers | Spleen | Spleen |
| 10 | chr10:50450000-50451800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 11 | chr10:50450200-50451400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
| 12 | chr10:50450400-50451600 | Enhancers | Pancreas | Pancrea |
| 13 | chr10:50450600-50451400 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
| 14 | chr10:50450600-50451400 | Enhancers | Liver | Liver |
| 15 | chr10:50450800-50451400 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
| 16 | chr10:50450800-50451400 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
| 17 | chr10:50450800-50451400 | Enhancers | Placenta | Placenta |
| 18 | chr10:50450800-50452200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
| 19 | chr10:50450800-50452400 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
| 20 | chr10:50450800-50452400 | Enhancers | Primary B cells from cord blood | blood |
| 21 | chr10:50450800-50452400 | Enhancers | Primary B cells from peripheral blood | blood |
| 22 | chr10:50451000-50451400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
| 23 | chr10:50451000-50451400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
| 24 | chr10:50451000-50451600 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
| 25 | chr10:50451000-50451600 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
| 26 | chr10:50451000-50452000 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
| 27 | chr10:50451000-50452200 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
| 28 | chr10:50451000-50452200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
| 29 | chr10:50451000-50452200 | Enhancers | Adipose Nuclei | Adipose |
| 30 | chr10:50451000-50454200 | Weak transcription | Esophagus | oesophagus |
| 31 | chr10:50451200-50451400 | Bivalent Enhancer | H9 Cell Line | embryonic stem cell |
| 32 | chr10:50451200-50451400 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
| 33 | chr10:50451200-50451400 | Enhancers | Brain Cingulate Gyrus | brain |
| 34 | chr10:50451200-50451600 | Weak transcription | Brain Substantia Nigra | brain |
| 35 | chr10:50451200-50451800 | Enhancers | Brain Hippocampus Middle | brain |
| 36 | chr10:50451200-50452000 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
| 37 | chr10:50451200-50452400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
